← All trials
NCT04035876
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 16, 2019
- Primary completion
- Dec 31, 2021
- Completion date
- Dec 31, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Zhejiang UniversityLead sponsor
- Zhengzhou UniversityCollaborator
- Jilin UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Sichuan UniversityCollaborator
- Fudan UniversityCollaborator
- Tianjin Medical UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
- Zhejiang UniversityReponsible party - principal investigator
- Hangzhou Hospital of Traditional Chinese MedicineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.